Recent Advances in the Management of Cancer-Associated Thrombosis: New Hopes but New Challenges.

Cancers (Basel) · 2019 · PMC6357110 · PMID 30634638

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A recent meta-analysis pooling results from both the Hokusai VTE Cancer and SELECT-D trials reported a numerically lower rate of VTE recurrence in patients treated with DOAC compared to dalteparin, but this did not reach statistical significance (RR 0.65, 95% CI 0.42–1.01, I2 17%).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.